Clinical Lymphoma Myeloma & Leukemia

译名:临床淋巴瘤、骨髓瘤与白血病

SCIEJCR Q1中科院4区

3-5

2026

影响因子区间

65天

平台估算

投稿周期

6%

2025

中国作者发文占比

1969 USD

费用说明

收费

期刊简介:Clinical Lymphoma, Myeloma & Leukemia is a peer-reviewed monthly journal that publishes original articles describing various aspects of clinical and translational research of lymphoma, myeloma and leukemia. Clinical Lymphoma, Myeloma & Leukemia is devoted to articles on detection, diagnosis, prevention, and treatment of lymphoma, myeloma, leukemia and related disorders including macroglobulinemia, amyloidosis, and plasma-cell dyscrasias. The main emphasis is on recent scientific developments in all areas related to lymphoma, myeloma and leukemia. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.

【译文】临床淋巴瘤、骨髓瘤和白血病是一本同行评审的月刊,发表描述淋巴瘤、骨髓瘤和白血病临床及转化研究各个方面的原创文章。该期刊致力于发表关于淋巴瘤、骨髓瘤、白血病及其相关疾病(包括巨球蛋白血症、淀粉样变性、浆细胞异常)的检测、诊断、预防和治疗的文章。主要关注与淋巴瘤、骨髓瘤和白血病相关的所有领域的最新科学发展。感兴趣的具体领域包括临床研究和机制方法;药物敏感性和耐药性;基因和反义治疗;病理学、标志物和预后指标;化学预防策略;多模式治疗以及各种方法的整合。

出版社
Elsevier BV
语言
English
学科
医学
ISSN
2152-2669
eISSN
2152-2650
出版频率
双月刊
创刊年份
2010
投稿网址
http://ees.elsevier.com/clml/
最近更新
2026-04-02 18:16:40
Clinical Lymphoma Myeloma & Leukemia

指标当前值近三年趋势
JCR分区Q1
暂无
中科院分区4区
暂无
影响因子区间3-5
暂无